2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Heart Septal Defects: new trials by email Literature Review of Heart Septal Defects trials Research Report on Heart Septal Defects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia Flecainide - Patent Foramen Ovale, Atrial Arrhythmia | Phase 3 | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 186 | 2022-03-23 | 2026-09-09 |
| Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine PFO closure device, Aspirin and clopidogrel, Triptans - PFO - Patent Foramen Ovale, Migraine | Phase 3 | Active not recruiting | Guangdong Provincial People's Hospital | 440 | 2021-08-12 | 2025-03-12 |
Foramen Ovale, Patent (2) · Atrial Fibrillation (1) · Ischemic Stroke (1) · Migraine Disorders (1)
Brain Diseases (2) · Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Heart Defects, Congenital (2) · Heart Diseases (2) · Heart Septal Defects, Atrial (2) · Nervous System Diseases (2) · Arrhythmias, Cardiac (1) · Cerebrovascular Disorders (1) · Headache Disorders (1) · Headache Disorders, Primary (1)
Aspirin (1) · Clopidogrel (1) · Flecainide (1) · Tryptamines (1)
Assistance Publique - Hôpitaux de Paris (1) · Guangdong Provincial People's Hospital (1)
China (1) · France (1)